Intellectual Property India Publishes Patent Application for 'Exatecan Hydroxylamine Derivative And Use Thereof' Filed by Hangzhou Adcoris Biopharma Co. Ltd.

MUMBAI, India, April 20 -- Intellectual Property India has published a patent application (202637044396 A) filed by Hangzhou Adcoris Biopharma Co. Ltd., Zhejiang, China, on April 7, for 'exatecan hydroxylamine derivative and use thereof.'

Inventor(s) include Miao, Zhenwei; Huang, Yunsheng; and Li, Yaowu.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to a method for preparing a series of exatecan derivatives containing a hydroxylamine structure substitution and pharmaceutically acceptable salts thereof, and the use thereof in the field of anti-tumor. These exatecan derivatives not only have a good acti...